| |
|
Form Serial Number: |
DA20210216E00275
|
| 1.
Date of relevant event: |
09/02/2021
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01951 |
| 4.
Name of listed corporation: |
Jinxin Fertility Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
2,509,501,802 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Wilcox |
| (Other names) |
John Gorden |
|
|
|
| 10.
Name of director (Chinese): |
|
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
80,000,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 342,688,755 | 14.11 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 342,688,755 | 13.66 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| John G. Wilcox, M.D., A Medical Corporation | 875 S Madison Ave, Pasadena, CA 91106 (United States of America) | John Gorden Wilcox | 100.00 | Y | |
| HRC Investment Cayman, LLC | Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands (Cayman Islands) | John G. Wilcox, M.D., A Medical Corporation | 23.65 | Y | |
| HRC Investment Holding, LLC | 135 South Rosemead Blvd, Pasadena CA, United States (State of Delaware) | HRC Investment Cayman, LLC | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| Bradford Alan Kolb | Addresses of individuals are not displayed. | 342,688,755 |
| Robert Boostanfar | Addresses of individuals are not displayed. | 342,688,755 |
| Daniel Alan Potter | Addresses of individuals are not displayed. | 342,688,755 |
| Jane Leigh Frederick | Addresses of individuals are not displayed. | 342,688,755 |
| David Tourgeman | Addresses of individuals are not displayed. | 342,688,755 |
| Jeffrey Robert Nelson | Addresses of individuals are not displayed. | 342,688,755 |
| Michael Alan Feinman | Addresses of individuals are not displayed. | 342,688,755 |
| Total number of shares in which a director is interested under sections 317 and 318 | 342,688,755 |
|
| |
| 34.
Supplementary information: |
Box 24: The percentage level of interest in the shares has reduced because of completion of the Company's placing of 80,000,000 new shares under general mandate (as disclosed in the announcement of the Company dated February 2, 2021)
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
|
Date of filing this Form 3A: |
16/02/2021
(dd/mm/yyyy)
|
| |